SAT-193 - AKR1C3 silencing in adipose lowers circulating androgens: potential implications for PCOS

Late-Breaking Poster Presenter(s)

• AD

  Aditi Dubey, PhD

  Alnylam Pharmaceuticals
  Cambridge, Massachusetts, UNITED STATES

Co-Author(s)

• AM

  Ainaz Malekoltojari, MS

  Alnylam Pharmaceuticals
  Cambridge, Massachusetts, United States
• MK

  Mark Keibler, PhD

  Alnylam Pharmaceuticals
  Cambridge, Massachusetts, United States
• RT

  Roxanne Tymon, MS

  Alnylam Pharmaceuticals
  Cambridge, Massachusetts, United States
• MY

  Mark Yao, BS

  Alnylam Pharmaceuticals
  Cambridge, Massachusetts, United States

Senior Author/Primary Investigator(s)

• EM

  Eleftheria Maratos-Flier, MD

  HMS-BIDMC, Alnylam Pharmaceuticals
  Cambridge, Massachusetts, United States
• EF

  Elane Fishilevich, PhD

  Alnylam Pharmaceuticals
  Cambridge, Massachusetts, United States